Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase 3 2

Status

Unknown 3Completed 1

Sponsor Class

OTHER 402INDUSTRY 91NIH 65NETWORK 26UNKNOWN 4OTHER_GOV 3FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4Thoracic 2Breast 1

Conditions

Breast Neoplasms 21Stomach Neoplasms 14Colorectal Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Rectal Neoplasms 7Triple Negative Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Small Cell Lung Carcinoma 4Lymphoma, Extranodal NK-T-Cell 4Esophageal Squamous Cell Carcinoma 4Esophageal Neoplasms 4Brain Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Head and Neck Neoplasms 3Vomiting 2Sarcoma 2Recurrence 2Nasopharyngeal Carcinoma 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2HER2-positive Breast Cancer 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Lung 1Radiation Injuries 1Platinum-resistant Recurrent Ovarian Cancer 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pain 1Ovarian Neoplasms 1

Interventions

pyrotinib 1Vinorelbine 1Temozolomide 1Gefitinib 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × UNKNOWN × Brain Neoplasms × Clear all
NCT03933982 2019-05-29

Pyrotinib

ChineseAMS

Phase 2 Unknown
30 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT02654106 2017-06-06

SRTRBM

ChineseAMS

Phase 2 Completed
65 enrolled
CNS

Brain Neoplasms, Meningeal Carcinomatosis

NCT00663689 2008-04-22

Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer

GuangdongPPH

Phase 2 Unknown
45 enrolled
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00614809 2008-02-22

Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer

GuangdongPPH

Phase 2 Unknown
45 enrolled
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡